Kaiser Permanente and University of Michigan receive $10.5 million to advance AI tools for cardiovascular disease screening and emergency response.
Key Details
- 1American Heart Association awarded $10.5M to two research teams for AI projects in cardiovascular care.
- 2Kaiser Permanente's project will use AI to detect kidney and liver disease on echocardiograms and conduct a multi-center clinical trial.
- 3University of Michigan's project will develop AI-guided wearable sensors for improved CPR outcomes.
- 4Cardiovascular disease caused 19.41 million global deaths in 2021; over 400,000 cardiac arrest deaths occur yearly in the U.S.
- 5AI aims to improve health professional decision making and treatment effectiveness for leading causes of death.
Why It Matters
These grants support pioneering research integrating AI with medical imaging and sensing to enable earlier disease detection and more personalized emergency care. The projects have potential to transform outcomes for cardiovascular, kidney, and liver conditions, which together cause millions of deaths globally.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.